Wikidata

(Q63831492)

English

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus. (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Latvia
0 references
Lithuania
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Philippines
0 references
Poland
0 references
Romania
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
Thailand
0 references
Ukraine
0 references
United Kingdom
0 references
start time
18 June 2010
0 references
end time
21 April 2017
0 references
number of participants
14,752
0 references
minimum age
18 year
0 references
maximum age
130 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63831492&oldid=2083674307"